← SynDRA
GSK-3179106
SynDRA canonical compound SYN0038119 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | RET |
| Mechanism of action | RET tyrosine kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- RET tyrosine kinase inhibitor
- RET INHIBITOR
Cross-references
Synonyms
- Gsk3179106
- GSK3179106
- RET Kinase inhibitor 1
- SCHEMBL16055027
- CHEMBL3355009
- IDXKJSSOUXWLDB-UHFFFAOYSA-N
- CS-7799
- HY-100459
- 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide
- DY8BBK4G3C
- UNII-DY8BBK4G3C
- RefChem:144521
- orb1301746
- SCHEMBL31060944
- C22H21F4N3O4
- GLXC-20190
- CQC85664
- EX-A3001
- s8821
- ZB1508
- AKOS037648939
- GSK3179106?
- AC-36286
- BS-16078
- DA-73916
- C92221
- F833520
Look up GSK-3179106 in the interactive SynDRA portal →